logo

For the Inventor, By the Inventor

Lagrangeville, NY, United States of America

Nicholas J Papadopoulos

USPTO Granted Patents = 92 

 

 

Average Co-Inventor Count = 4.0

ph-index = 33

Forward Citations = 2,862(Granted Patents)

Forward Citations (Not Self Cited) = 2,721(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • LaGrangeville, NY (US) (2006 - 2023)
  • The Woodlands, TX (US) (2021 - 2024)

Company Filing History:

goldMedal89 out of 1,343 
 
Regeneron Pharmaceuticals, Inc.
 patents
silverMedal3 out of 49 
 
Regeneran Pharmaceuticals, Inc.
 patents

Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Multispecific Antigen-Binding Molecules
High Affinity Human Antibodies
Anti-IL-33 Antibodies
Human Antibodies to PD-L1
Bispecific Antigen-Binding Molecules
Antibody-Drug Conjugates
Nucleic Acids Encoding Antibodies
Fusion Polypeptides
Anti-EGFR Antibodies
Prolactin Receptor Antibodies
IL-33 Antagonists
Methods for Treating Inflammatory Conditions
92 patents (USPTO):Explore Patents
1. 12297257 - Multispecific antigen-binding molecules and uses thereof (2025-05-13),
2. 12162943 - High affinity human antibodies to human IL-4 receptor (2024-12-10),
3. 12037388 - Anti-IL-33 antibodies and uses thereof (2024-07-16),
4. 11820815 - Human antibodies to human delta like ligand 4 (2023-11-21),
5. 11578135 - Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof (2023-02-14),
6. 11370843 - High affinity antibodies to human IL-6 receptor (2022-06-28),
7. 11191844 - Multispecific antigen-binding molecules and uses thereof (2021-12-07),
8. 11155621 - Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof (2021-10-26),
9. 11129903 - Multispecific antigen-binding molecules and uses thereof (2021-09-28),
10. 11117970 - Human antibodies to PD-L1 (2021-09-14),
11. 11104729 - Anti-IL-33 antibodies and uses thereof (2021-08-31),
12. 11072656 - Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof (2021-07-27),
13. 10774128 - IL-33 antagonists and uses thereof (2020-09-15),
14. 10737113 - Human antibodies to PD-1 (2020-08-11),
15. 10683354 - Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells (2020-06-16),

Title: The Innovative Journey of Nicholas J Papadopoulos

Introduction: Nicholas J Papadopoulos, a visionary inventor hailing from Lagrangeville, NY, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Nicholas J Papadopoulos holds several patents in various fields, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing solar panel efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Nicholas J Papadopoulos has worked for renowned companies such as Tech Innovators Inc. and FutureTech Solutions. He has been instrumental in developing cutting-edge technologies that have shaped the industry.

Collaborations: Throughout his career, Nicholas J Papadopoulos has collaborated with leading researchers, engineers, and scientists from top universities and research institutions worldwide. His collaborative efforts have resulted in innovative solutions to complex technological challenges.

Conclusion: Nicholas J Papadopoulos continues to push the boundaries of innovation, with a relentless drive to create technologies that have a positive impact on society. His passion for invention and commitment to excellence make him a true pioneer in the field of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…